In addition, Cetuximab directs cytotoxic immune effector cells towards the EGFR overexpressed tumor, inhibits the cell cycle at the G1 phase, and induces apoptosis through the expression of the caspase-8 and Bcl-2 proteins [25]. This evidence concerns the gene EGFR and neoplasm.